Secukinumab

Pediatric Scaling Diseases: An Approach to Pediatric Psoriasis
Pediatric Psoriasis
by Jacqueline McKesey, MD, MS on
Dr. Lawrence F. Eichenfield, meeting co-chair for the 17th Annual Women’s and Pediatric Dermatology Seminar, kicked off session III with a superb talk titled “Scaling the Heights…and Below, Pediatric Scaling Diseases: Psoriasis and Others”,  giving us a bird’s eye view on the old and the new regarding pediatric psoriasis. Dr. Eichenfield is a complete rock star and served as a valued …
Dermatology Industry Joins Fight Against COVID-19
Dermatology industry joins fight against covid-19
by Allison Sit on
EPI Health has graciously supported the COVID-19 News and Resource Center. Companies in the dermatology industry are playing a role in the fight against COVID-19. From researching possible treatments and vaccines to modifying production lines for essential products, the following is a listing of dermatology companies and their COVID-19 efforts: AbbVie is researching whether its drug KALETRA …
Interleukin-17 Inhibitors Therapeutic Cheat Sheet
Interleukin-17
by Angelo Landriscina, MD on
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients.  In this installment of our Therapeutic Cheat Sheet series, we’ll cover everything you need to know to start and monitor your patients on IL-17 blocking therapies. [caption id="attachment_8301" align="alignleft" width="612"] Click image to en …